Iran's campaign to inoculate its population against the coronavirus and promote itself as an emerging vaccine manufacturer inched on as health authorities announced Tuesday that the country's third homegrown vaccine has reached the phase of clinical trials.
The government said 20,000 volunteers in Tehran and other cities will soon receive Iran's new vaccine, called Fakhra, which an official described to state-run media as being "100% safe". Earlier this week, the government launched a vaccine production factory it claims can make 3 million doses a day.
The vaccine introduced Tuesday on state TV was created by an affiliate of Iran's Defense Ministry, known as the Research and Innovation Organization, ABC News reported.
